Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
Holding SRPT?
Track your performance easily

Sarepta Therapeutics (SRPT) Financial Statements

2,989 Followers

Sarepta Therapeutics Financial Overview

Sarepta Therapeutics's market cap is currently ―. The company's EPS TTM is $0.404; its P/E ratio is 307.86; Sarepta Therapeutics is scheduled to report earnings on October 30, 2024, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 362.93M$ 413.46M$ 396.78M$ 331.82M$ 261.24M
Gross Profit$ 362.93M$ 413.46M$ 547.12M$ 331.82M$ 239.00M
EBIT$ 18.76M$ 96.17M$ 45.60M$ -27.95M$ -9.36M
EBITDA$ 27.48M$ 104.92M$ 56.98M$ -17.02M$ 1.43M
Net Income Common Stockholders$ 6.46M$ 36.12M$ 45.66M$ 8.42M$ -23.94M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.46B$ 1.39B$ 1.68B$ 1.73B$ 1.86B
Total Assets$ 3.42B$ 3.22B$ 3.26B$ 3.11B$ 3.13B
Total Debt$ 1.37B$ 1.38B$ 1.40B$ 1.37B$ 1.36B
Net Debt$ -90.61M$ -11.44M$ -279.39M$ -362.02M$ -496.04M
Total Liabilities$ 2.35B$ 2.26B$ 2.41B$ 2.35B$ 2.38B
Stockholders Equity$ 1.08B$ 961.19M$ 859.34M$ 764.36M$ 741.41M
Cash Flow-
Free Cash Flow$ -14.22M$ -284.52M$ -73.70M$ -155.62M$ -38.14M
Operating Cash Flow$ 14.94M$ -242.08M$ -54.66M$ -114.71M$ -122.23M
Investing Cash Flow$ -98.53M$ 218.80M$ -64.36M$ -210.57M$ 96.63M
Financing Cash Flow$ 39.92M$ 22.14M$ 1.94M$ 15.40M$ 5.86M
Currency in USD

Sarepta Therapeutics Earnings and Revenue History

Sarepta Therapeutics Debt to Assets

Sarepta Therapeutics Cash Flow

Sarepta Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis